1. Home
  2. ZLAB

as of 07-29-2026 4:00pm EST

$18.31
$0.31
-1.66%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Founded: 2013 Country:
China
China
Employees: N/A City: SHANGHAI
Market Cap: 2.0B IPO Year: 2017
Target Price: $49.60 AVG Volume (30 days): 714.0K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.05 EPS Growth: 38.46
52 Week Low/High: $15.96 - $39.64 Next Earning Date: 05-07-2026
Revenue: $460,156,000 Revenue Growth: 15.33%
Revenue Growth (this year): 9.75% Revenue Growth (next year): 26.03%
P/E Ratio: -372.80 Index: N/A
Free Cash Flow: -158890000.0 FCF Growth: N/A

AI-Powered ZLAB Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 71.27%
71.27%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Zai Lab Limited (ZLAB)

Buy
ZLAB Jul 1, 2026

Avg Cost/Share

$19.05

Shares

1,736

Total Value

$33,070.80

Owned After

80,737

SEC Form 4

Du Ying

Chairperson & CEO

Sell
ZLAB Jun 30, 2026

Avg Cost/Share

$18.53

Shares

7,026

Total Value

$130,219.88

Owned After

1,203,784

SEC Form 4

Du Ying

Chairperson & CEO

Sell
ZLAB Jun 26, 2026

Avg Cost/Share

$17.46

Shares

24,543

Total Value

$428,545.32

Owned After

1,203,784

SEC Form 4

Chen Yajing

Chief Financial Officer

Sell
ZLAB Jun 26, 2026

Avg Cost/Share

$17.46

Shares

2,264

Total Value

$39,531.70

Owned After

35,691

SEC Form 4

Edmondson Frazor Titus III

Chief Legal Officer

Sell
ZLAB Jun 26, 2026

Avg Cost/Share

$17.46

Shares

4,103

Total Value

$71,642.48

Owned After

30,346

SEC Form 4

Lis William

Director

Sell
ZLAB Jun 22, 2026

Avg Cost/Share

$18.09

Shares

7,040

Total Value

$127,353.60

Owned After

50,437

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q1

Q1 2026 Earnings

8-K BUY

May 7, 2026 · 100% conf.

AI Prediction BUY

1D

+3.72%

$20.50

Act: -5.54%

5D

+10.26%

$21.79

Act: +2.86%

20D

+8.97%

$21.54

Act: -15.91%

Price: $19.77 Prob +5D: 100% AUC: 1.000
0001628280-26-031624

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1784333300.425bb35a

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 26, 2026 · 100% conf.

AI Prediction BUY

1D

+3.72%

$20.42

Act: -2.49%

5D

+10.26%

$21.71

Act: -1.85%

20D

+8.97%

$21.46

Price: $19.69 Prob +5D: 100% AUC: 1.000
0001704292-26-000014

zlab-20260226false000170429200017042922026-02-262026-02-260001704292dei:AdrMember2026-02-262026-02-260001704292us-gaap:CommonStockMember2026-02-262026-02-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026


ZAI LAB LIMITED

(Exact name of registrant as specified in its charter)


Cayman Islands001-3820598-1144595 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

899 Halei Road Building B, Pudong Shanghai, China 201203

314 Main Street 4th Floor, Suite 100 Cambridge, MA, USA02142 (Address of principal executive offices)(Zip Code)

+86 21 6163 2588 +1 857 706 2604 (Registrant’s Telephone Number, Including Area Code) Not Applicable (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s) Name of each exchange on which registered

American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per shareZLABThe Nasdaq Global Market Ordinary Shares, par value $0.000006 per share*9688The Stock Exchange of Hong Kong Limited

*Included in connection with the registration of the American Depositary Shares with the Securities and Exchange Commission. The ordinary shares are not registered or listed for trading in the United States but are listed for trading on The Stock Exchange of Hong Kong Limited Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition. On February 26, 2026, Zai Lab Limited issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits

Exhibit No.Description

99.1Press Release issued by Zai Lab Limited on February 26, 2026

104The cover page of this report is formatted in Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ZAI LAB LIMITED

By:/s/ Yajing Chen Yajing Chen

Chief Financial Officer

Date: February 26, 2026

2025
Q3

Q3 2025 Earnings

8-K

Nov 6, 2025

0001704292-25-000023

zlab-20251106false000170429200017042922025-11-062025-11-060001704292dei:AdrMember2025-11-062025-11-060001704292us-gaap:CommonStockMember2025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025


ZAI LAB LIMITED

(Exact name of registrant as specified in its charter)


Cayman Islands001-3820598-1144595 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

899 Halei Road Building B, Pudong Shanghai, China 201203

314 Main Street 4th Floor, Suite 100 Cambridge, MA, USA02142 (Address of principal executive offices)(Zip Code)

+86 21 6163 2588 +1 857 706 2604 (Registrant’s Telephone Number, Including Area Code) Not Applicable (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s) Name of each exchange on which registered

American Depositary Shares, each representing 10 Ordinary Shares, par value $0.000006 per shareZLABThe Nasdaq Global Market Ordinary Shares, par value $0.000006 per share*9688The Stock Exchange of Hong Kong Limited

*Included in connection with the registration of the American Depositary Shares with the Securities and Exchange Commission. The ordinary shares are not registered or listed for trading in the United States but are listed for trading on The Stock Exchange of Hong Kong Limited Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition. On November 6, 2025, Zai Lab Limited issued a press release announcing its financial results for the third quarter of 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits

Exhibit No.Description

99.1Press Release issued by Zai Lab Limited on November 6, 2025

104The cover page of this report is formatted in Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ZAI LAB LIMITED

By:/s/ Yajing Chen Yajing Chen

Chief Financial Officer

Date: November 6, 2025

Share on Social Networks: